
Cephalgo
ClaimedSpeech biomarker company in Strasbourg, France, for CNS clinical trials
About
Cephalgo is a speech biomarker company in Strasbourg, France. It measures real disease progression in CNS clinical trials (Alzheimer's, Parkinson's, Huntington's, ALS, DM1 and other neuromuscular diseases, and psychiatry) from speech recordings sponsors already hold, from site visits and from home sessions, with readings that stay stable across phone and software changes. Cephalgo also checks recorded rating interviews (Trial QC) so rater effects do not read as participant change.
Cephalgo serves pharmaceutical, biotech sponsors and CROs. Cephalgo converts speech recordings from site visits, home sessions and existing archives into measures of disease progression in CNS clinical trials. Cephalgo reviews recorded rating interviews to separate rater effects from participant change, with readings that hold steady when phones and software vary.
Cephalgo is headquartered in Strasbourg, France, and operates from that city. Cephalgo follows a B2B business model for work with other companies. Cephalgo has a team of about 6 people in total.
Listed competitors
Show 6 more similar companies
Also in this space
Arbiter uses voice analytics to detect patient health changes and predict risks for care teams.
Shares Voice AI, HealthTech
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotech, MedTech
Global life sciences company providing diagnostic and biopharma laboratory services.
Shares HealthTech, MedTech
Leveraging the adaptive immune system to diagnose and treat disease.
Shares Biotech, HealthTech
Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
Shares Biotech, HealthTech
Develops a computational model of the human body for drug discovery and development.
Shares Biotech, HealthTech
Cephalgo focuses on speech biomarkers for CNS clinical trials in Alzheimer's, Parkinson's, Huntington's, ALS, DM1 and other neuromuscular diseases, and psychiatry, including Trial QC checks of recorded rating interviews. Winterlight Labs and Sonde Health work on voice recognition and vocal biomarker platforms for cognitive assessment, early detection and monitoring of health conditions.
Signals agent
Reach companies that have budget right now
Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.
- Just raised a roundFresh budget, the week it lands
- Hiring sales and marketingGo-to-market roles mean money to spend
- Hiring fastA jump in open roles across the company
- In the newsLaunches and announcements worth a message
- The decision makerWho to contact, with a message you can edit
Is your startup an alternative to Cephalgo?
People comparing tools land here. Get listed beside these.
Copy Cephalgo's SEO strategy
How often they publish, which searches their posts chase and their newest posts. Then outrank them.
All funding rounds
Key facts
- Website
- cephalgo.com
- Headquarters
- Strasbourg, France
- Employees
- 6
- Business model
- B2B
Tech stack
Detected on cephalgo.com, last scanned 17 Nov 2026. Run your own scan
- Compliance
- GDPR
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Email provider
- Google Workspace
Measured, not editorial
Agent Readiness
Top 25%
Scan yoursSite Speed
Top 25%
PageSpeedData Trust
Top 25%
Reproducibility
Bottom 25%
Security
Click to scan
Agent Readiness
Can AI agents use your site?
Cephalgo scores 64. Check yours free in a few seconds, or let Max Agent rerun it daily.
Run it daily with Max AgentGet notified when Cephalgo changes
Used Cephalgo? Write a review and get $5 in credits
Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:
- Email finder
- Market Map Maker
- Agent Readiness scans
- Deep intel
- Tech stack scans
Frequently asked
Are there companies like Cephalgo?
Yes. We list 8 companies like Cephalgo, including Winterlight Labs, Sonde Health and MyndYou.
Who is Cephalgo for?
Cephalgo is for pharmaceutical and biotech sponsors and CROs. Cephalgo supports teams running CNS clinical trials in Alzheimer's, Parkinson's, Huntington's, ALS, DM1 and other neuromuscular diseases, and psychiatry that use speech recordings from site visits and home sessions.
Where is Cephalgo based?
Cephalgo is based in Strasbourg, France. Cephalgo has its headquarters in Strasbourg, France.
What does Cephalgo do?
It works with pharmaceutical and biotech sponsors and CROs.
Is Cephalgo trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Cephalgo is 89 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How many employees does Cephalgo have?
Cephalgo has approximately 6 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Cephalgo:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
Categories
Max Agent
Let Max Agent watch Cephalgo and its market for you
New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.
Free week
Starter listings, once
AI answers checked
Daily for 7 days
ChatGPT
Perplexity
Max Agent
$79 a month, or $9.99 with our badge on your site
AI answers checked
Every week
ChatGPT
Claude
Perplexity
Gemini

